14
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Melanocyte-Stimulating Hormone Release-Inhibiting Factor (MIF): Lack of Dopaminergic and Anticholinergic Activity

      research-article
      , ,
      Neuroendocrinology
      S. Karger AG
      MIF, Dopaminergic-cholinergic balance, Parkinson’s disease, Planaria

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In a sensitive animal model under the control of a dopaminergic-cholinergic balance, showing striking similarity to the extrapyramidal system, MIF did not possess dopaminergic or anticholinergic properties either with acute or chronic administration of the drug.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1977
          1977
          25 March 2008
          : 23
          : 3
          : 129-132
          Affiliations
          la Clinica delle Malattie Nervose e Mentali, Istituto di Anatomia comparata ‘G.B. Grassi’ and Istituto di Biologia e Zoologia generale, Rome
          Article
          122661 Neuroendocrinology 1977;23:129–132
          10.1159/000122661
          19714
          1d131961-f54f-4a2a-9308-222f2fde293d
          © 1977 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 04 November 1976
          : 03 February 1977
          Page count
          Pages: 4
          Categories
          Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Parkinson’s disease,Dopaminergic-cholinergic balance,MIF,Planaria

          Comments

          Comment on this article